The β3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease

Metabolism: Clinical and Experimental

Volumn 50, Issue 2, 2001, Pages 184-188

  Stangl, Karl ^a   Cascorbi, Ingolf ^a   Laule, Michael ^a   Stangl, Verena ^a   Meisel, Christian ^a   Wernecke, Klaus Dieter ^a   Ziemer, Sabine ^a   Baumann, Gert ^a   Roots, Ivar ^a   Hauner, Hans ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; ARGININE; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK FACTOR; STATISTICAL MODEL; ADULT; AGED; ANGIOGRAPHY; ATHEROGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GENE MUTATION; GENOTYPE; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SEX DIFFERENTIATION; SMOKING; WEIGHT GAIN;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS;

EID: 0035109950     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.20179     Document Type: Article

References (34)

1. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene
2. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns
3. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity
4. Classical risk factors and emerging elements in the risk profile for coronary artery disease
5. The beta 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight BMI abdominal fat blood pressure and reproductive history in an elderly Australian population
6. Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain
7. Effects of Trp64Arg mutation in the beta(3)-adrenergic receptor gene on weight loss body fat distribution glycemic control and insulin resistance in obese type 2 diabetic patients
8. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohorts
9. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity
10. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome
11. The beta 3-adrenergic receptor - A cause and cure of obesity?
12. Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance
13. Meta-analysis of the association of the Trp64Arg polymorphism in the beta-3 adrenergic receptor with body mass index
14. Meta-analysis of the association of Trp64Arg polymorphism of beta-3 adrenergic receptor gene with body mass index
15. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene
16. Role of the beta 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair
17. Beta 3-adrenergic receptor gene variant and Japanese NIDDM: A pitfall in meta-analysis
18. Lack of associations between serum leptin a polymorphism in the gene for the beta 3-adrenergic receptor and glucose tolerance in the Dutch population
19. Clinical features associated with the homozygous Trp64Arg mutation of the beta3-adrenergic receptor: No evidence for its association with obesity in Japanese
20. Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais
21. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort
22. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity
23. Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: The ARIC study. Atherosclerosis risk in communities
24. The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients
25. Variant of the beta3-adrenergic receptor gene and coronary atherosclerosis in Japanese subjects
26. Assessment of genetic markers for coronary thrombosis: Promise and precaution
27. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study
28. The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes
29. Insulin resistance. A multifaceted syndrome responsible for NIDDM obesity hypertension dyslipidemia and atherosclerotic cardiovascular disease
30. Tissue distribution of beta 3-adrenergic receptor mRNA in man
31. Regional variation in adipose tissue metabolism of severely obese premenopausal women
32. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects
33. No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue